Management of the Company
Management Board
Sławomir Ziegert – President of the Managing Board
Is a medical doctor, graduate of the Medical University in Gdańsk. He has been connected with the pharmaceutical industry for over sixteen years, working in Poland and abroad for such concerns as Eli Lilly, Egis Group (a part of Servier group) and Ipsen. He has got enormous business experience covering different sectors of the pharmaceutical industry, including biotechnology, in particular business development within the scope of endocrinology and treatment of diabetes. In 1993-2004 he worked in the Polish branch of Eli Lilly, one of the world’s leading pharmaceutical concerns and manufacturers of recombinant human insulin and insulin analogues, where he was responsible for the development of diabetes business, relations with the diabetes environment and governmental affairs. In 1998-2000 he was also Eli Lilly's Country Manager in Slovakia, supervising, among others, the development of sale of insulins and antibiotics. In 2004-2005 he was CEO of Egis Pharmaceuticals (a part of Servier group) where he was responsible for the Baltic States area. In 2006-2009 he was CEO of Ipsen Poland. Working for Ipsen Poland, he was responsible for introduction of somatostatin analogue and IgF1 to the Polish market and for improvement of efficiency of marketing and sales activities. He has taken many manager courses and training abroad. He is fluent in: English, Russian, German and Slovak. He is CEO of SciGen Ltd. Since 9 November 2009 he has been holding the position of the President of the Managing Board of the Company and is CEO of the Company.
Adam Wilczęga – Vice President of the Managing Board
He is a graduate of Warsaw School of Economics, where he obtained the title of MSc in economics. Moreover, in 1991 he completed managers training in Japan. His professional career started in 1979 at PTHZ Varimex in Warsaw where he worked as a section manager until 1984. In 1984-1989 he was employed as a director of Technical and Trade Information Centre in Cairo, Egypt. Then, in the period 1989-1991 he held the position of the Director of PTHZ Varimex in Warsaw. In 1991-1996 he was the president of the managing board of Future Trading Co. Sp. z o.o. (limited liability company) in Warsaw. He has been working in the Company since 1996, when he has become director for foreign co-operation and a Member of the Managing Board. Since 1998 he has been the president of the managing board of BIOTON TRADE Sp. z o.o. He is the a member of the board of directors of SciGen Ltd. From 1997 till 15 January 2009 he was holding the post of the President of the Managing Board. Since 15 January 2009 he has been v-ce President of the Managing Board and since March 2009 he has been holding the post of Director for Foreign Markets of the Company.
Waldemar Krzewski – Member of the Managing Board
He is a graduate of Medical University of Warsaw where he obtained the title of MSc in pharmacy in technological specialty. He also completed training concerning technology and good manufacturing practice principles and an internship at Glaxo, UK. His professional carrier started in 1980 at Tarchomińskie Zakłady Farmaceutyczne POLFA, where he worked until 1982 holding different posts, promoted to a shift master. Then in the period 1982-1984 he was an assistant at Zakład Farmacji Stosowanej Centralnego Wojskowego Szpitala Klinicznego (Applied Pharmacy Plant of the Central Military Clinical Hospital). In 1984- 1990 he was employed as a technologist, first at Tarchomińskie Zakłady Farmaceutyczne POLFA (until 1986) then from 1987 until 1990 at Zakłady Produkcji Farmaceutycznej in Duchnice. In 1990 he was appointed director of the plant at Zakłady Produkcji Farmaceutycznej in Duchnice and held that position until 1996 when he became CEO and a member of the Managing Board of Zakłady Produkcji Farmaceutycznej BIOLEK Sp. z o.o. and held the post until 1998. From 1998 till March 2009 he was holding the position of Production Director of BIOTON S.A. and since March 2009 he has been holding the position of Operations Director of the Company. Since 1998 he has been holding the function of a Member of the Managing Board of the Company.
Adam Aleksandrowicz – Member of the Managing Board
He is a graduate of the University of Gdańsk. He has got an extensive knowledge and experience in corporate finance management, in particular in companies operating in pharmaceutical industry. In 2006-2009 he worked for one of the world’s leading pharmaceutical concerns AstraZeneca holding the position of CFO in the companies of AstraZeneca concern in Poland (in 2006-2008) and in Russia (in 2008-2009). In both countries AstraZeneca employed several hundred workers in sales and marketing structures and supervision over clinical trials. In 2003-2005 he was bound with Pliva Kraków S.A. – being a part of the international pharmaceutical concern TEVA, where in 2003-2004 he held the position of CFO and in 2004-2005 the function of the President of the Managing Board. He was directly responsible for managing finances of the company, marketing and sales, business development and relations with the pharmaceutical market. In 2000-2003 he was employed at PriceWaterhouseCoopers in Poland as a manager in Corporate Finance department, where he was dealing with consultancy within the scope of mergers and acquisitions, evaluation of businesses, restructuring of companies and optimization of financing structures of company development. Before taking up the work at PriceWaterhouseCoopers he worked as Corporate Finance consultant at O.M. Investment Sp. z o.o and in investors relations department at Bank Gdański S.A. He has completed a number of postgraduate studies, among others Executive Management Program University of Michigan School of Business Administration in the United States. He is fluent in English and Russian. Since 13 January 2010 he has been holding the function of a Member of the Managing Board of the Company and the position of Financial Director of the Company.
SUPERVISORY BOARD
Ryszard Krauze – Chairman of the Board
Higher education. Graduate of Technical University of Gdańsk. In 1984-1986 he was employed at Centrala Handlu Zagranicznego Polservice in Warsaw. From 1987 until 1994 he was the owner and director of Innowacyjny Zakład Techniki Komputerowej Prokom, then Prokom Komputer System R. Krauze. In 1990 he founded ComputerLand Sp. z o.o. (at present ComputerLand S.A.) where he was holding the position of the president of the Managing Board until 1992 and in 1993-1994 he was the vice-president of the supervisory board of that company. Since 1990 he has been the president of the Managing Board of PROKOM Investments S.A. (formerly Prokom Software S.A.). Moreover, he held the position of the vice-chairman of the supervisory board of KOMA S.A. and the Polish Group S.A. and the vice-president of the supervisory board of Wirtualna Polska S.A. and Incenti S.A. He is also holding position of the chairman of the supervisory boards in the following companies: Bioton S.A., Petrolinvest S.A. and C. Ulrich założone w 1805 roku w Warszawie S.A., MD Investments SA, Polska Liga Koszykówki SA, Gdyński Klub Koszykówki Arka S.A. He is also holding the position of the president of the Board of Directors of SciGen, Hefei-SciGen-Bioton Biopharmaceutical Company Limited and a member of the Board of Directors of Occidental Resources Inc. He is a member of the Polish Business Roundtable. He sits at the senate of The Academy of International Economic and Political Relations in Gdynia. He is also the chairman of the board of Ryszard Krauze Foundation.
Zygmunt Solorz-Żak – Vice Chairman of the Board
Is one of the largest private entrepreneurs in Poland. At the end of 1980’s he founded a trade company Przedsiębiorstwo Zagraniczne SOLPOL, in the beginning of 1990’s he become engaged in mass media through investing funds in the publishing house Kurier Polski. In 1993 he launched the first private television in Poland- Polsat, which in the result of obtaining the concession became an all-Poland television in the same year. During several years of operation Telewizja Polsat has become one of the biggest broadcasters in Poland. Mr. Solorz-Żak is also the founder of the biggest Polish satellite TV platform, Cyfrowy Polsat S.A. Zygmunt Solorz-Żak has got an extensive experience as regards work within statutory bodies of commercial companies, sitting in the Supervisory Boards of such companies as Telewizja Polsat S.A., Cyfrowy Polsat S.A., Sferia S.A., Invest-Bank S.A. and PAI Media S.A. Since 6 April 2009 he has been holding the function of a Member of the Supervisory Board of the Company, and since 22 September 2009 – Vice-Chairman of the Supervisory Board.
Piotr Borowicz – Member of the Board
He is a graduate of the Faculty of Chemistry of the University of Warsaw. He also holds an academic degree of PhD in chemistry obtained at the Warsaw University of Technology. Moreover he completed the course in enterprise management CORP-MAN (at Stockholm School of Economics) and courses within the scope of quality systems. He also obtained 1st degree of Professional Specialization in Civil Engineering within the scope of chemistry in specialty: technology of finished forms. His professional career started in 1970 at Tarchomińskie Zakłady Farmaceutyczne POLFA, where he worked as a technologist until 1985. In 1986 he started working at Institute of Biotechnology and Antibiotics (IBA) as a manager of enzymatic transformation laboratory. In 1992-1995 he held the position of deputy director for technology there, and since March 1996 he has been director of IBA. He is also a member of the supervisory board of BIOTON TRADE Sp. z o.o. Since 24 May 1994 he has been holding the function of the Member of the Supervisory Board of the Company (with an interval in the period between 26 February 2004 and 21 September 2004).
Leon Bushara – Member of the Board
A graduate of Brown University in the USA. He has been connected with the biotechnological sector and the biggest global pharmaceutical concerns for years. For over 13 years he was working for the Swiss concern Serono SA - one of the biggest biotechnological companies from outside USA, holding the function of the Vice-President and a member of the Executive Committee. In Serono Mr. Bushara was responsible, among others, for the strategic development, implementation and supervision over the key transactions conducted by Serono both within the scope of acquisition of companies and biotechnological products. Since 2007 Serono has been a part of the German concern Merck-Serono. In 2006 Mr. Bushara was appointed CEO of the British biotechnological company Astex Therapeutics Ltd specializing in development of modern oncological medicines.
Tomasz Buzuk – Member of the Board
A graduate of the Faculty of Law and Administration of the University of Gdańsk. In 2001 he completed the Study of Investment Adviser and in 2002 graduated the Faculty of Management of the University of Gdańsk. Legal adviser, a member of the Regional Chamber of Legal Advisers in Gdańsk. Since 2000 has been employed at PROKOM Software S.A. and then at PROKOM Ivestments S.A., since 2006 as a legal adviser. In the course of his work at the companies of the group PROKOM Software S.A. and PROKOM Investments S.A. he was involved in legal service of comprehensive IT and capital projects and programs aiming at raising funds for investment projects. He holds the function of a Member of the Managing Board of PROKOM Investments SA MD Investments SA, Osiedle Wilanowskie Sp. z o.o., and a Member of the Supervisory Boards of Bioton SA, Petrolinvest SA, Polnord SA, Novabrik Polska Sp. z o.o.
Maciej Grelowski – Member of the Board
University education in economics. Lecturer at academic schools in management and corporate governance, he also gained experience as corporate adviser. In 1993-2004 he was the president of the managing board of Orbis S.A. He was a member of the supervisory boards of: OFE Kredyt Bank in the years 2001-2004, Softbank S.A. in the years 2004-2005, Opoczno S.A. in the years 2006-2007. Until February 2007 he was an adviser of the managing board of Operator Logistyczny Paliw Płynnych Sp. z o.o. and in the period 2005-2006 he was the president of Polski Instytut Dyrektorów. He was holding the position of a member of the supervisory board of PROKOM S.A. and Eurofilms S.A. At present he is a member of the managing board of Centrum Zamek Sp. z o.o. and is a member of the supervisory board of Bioton S.A., Polnord S.A. and Ergis S.A.
Rafał Juszczak – Member of the Board
Graduate of the University of Gdańsk (history), in 1996 was awarded the title Mastere Spécialisé Banque et Finance of Ecole Supérieure de Commerce in Rouen. He holds the position of the Vice-President of the Managing Board of Prokom Investments S.A., where he is responsible for contacts with international financial institutions, supervision over listed companies from the Prokom Group and actions within the scope of mergers and acquisitions. Over the last two years he was the president of First Ukrainian International Bank (FUIB) in Kiev. As the president of FUIB he successfully carried out restructuring of the bank's debts reaching 500 million USD. In 2005-2008 Rafał Juszczak was connected with the biggest Polish bank PKO BP S.A., as managing director in the corporate banking section, Member of the Managing Board and then President of the Managing Board (2007). Before, he worked in the Warsaw branch of Société Generale, and then in Bank Handlowy/Citibank, where he participated in preparation of strategic projects and was engaged in the merger of Bank Handlowy and Citibank Polska. In 2001 he held the position of a director of the Own Settlements Department, and was responsible for its restructuring process. Then he managed the Corporate Customer Service Department. In March 2004 he was appointed the manager of the Small Enterprises Section within Citibank Retail Banking Sector. He is a member of the supervisory board of Petrolinvest S.A.
Barbara Ratnicka-Kiczka – Member of the Board
Higher education. She is a graduate of the Faculty of Law and Administration of the University of Gdańsk. In 1982 she completed legal training at the Regional Court in Gdańsk. In 1982-1983 she was employed as an assistant at the Department of Economic Law at the Faculty of Law and Administration of the University of Gdańsk. In 1984-1986 she worked as a barrister trainee at Zespół Adwokacki (Barristers Chamber) No. 1 in Sopot. Since 1986 she has been running the legal firm in Gdańsk, Kancelaria Adwokacka B. Ratnicka-Kiczka. Since 7 April 2004 she has been a Member of the Supervisory Board of the Company.
Andre Spark – Member of the Board
He is a graduate of Cornell University (economics), Harvard University (philosophy) and University of Michigan (PhD in law). Vice-President of the Managing Board of Prokom Investments S.A. In the previous years he held the function of Senior Banker in European Bank for Reconstruction and Development (EBRD) in London, he was a director in Credit Suisse First Boston (Europe) Ltd in London and Vice-President of the Managing Board of Credit Suisse First Boston (Polska) S.A. (a brokerage which was the leader of IPO for the companies Agora SA, Prokom Software S.A. and Bank Pekao SA). In the past Mr. Andre Spark held also the function of a Member of the Managing Board of Prokom Investments S.A and Prokom Internet S.A. He started his professional career as legal adviser at Cravath, Swaine & Moore law firm in New York. He is a member of the supervisory board of Petrolinvest S.A.
Joanna Szymańska-Bulska – Member of the Board
A graduate of the Faculty of Medicine of Silesian Medical University in Katowice. Holds the MBA title in International Business which she has earned during the post graduate studies at the University of Economics in Katowice and Graduate School of International Business of the University of Bristol, UK. After having obtained the diploma of a medical doctor, in 1989-1992 she worked in a hospital as an intern and junior assistant. She has been connected with the pharmaceutical industry since 1992. In 1992-1999 she worked in the Swiss pharmaceutical company Ciba Geigy (later Novartis), within the areas of sales and marketing, starting with the position of a scientific adviser and ending in 1999 as a Trade Marketing Manager. Then, in 1999-2006 she was associated with the biggest European distributor of pharmaceutical products Phoenix Pharma AG, where in the beginning she held the position of foreign investments director at the company’s head office in Germany. After her return to Poland in 2000, she was employed at Phoenix Pharma Polska Sp. z o.o. as a member of the managing board and she was an executive director responsible for sales and marketing. In 2001-2006 she was the president of the managing board and CEO of Phoenix Pharma Polska Sp. z o.o. In 2000-2003 she was a member of the supervisory board of Izba Chemii i Farmacji (Chamber of Chemistry and Pharmation) at Polska Konfederacja Pracodawców Prywatnych – Lewiatan (Polish Confederation of Private Employers), and in 2003-2006 she was a member of the managing board of Izba Gospodarcza Farmacja Polska (Economic Chamber Polish Pharmacy). At the turn of 2006 and 2007 she was an adviser of the Minister of Health. From 2007 till March 2009 she was holding the position of Director for Foreign Markets of the Company, and since March 2009 she has been holding the position of Commercial Director. From 6 March 2008 till 26 June 2009 she was a Member of the Managing Board of the Company. She is a member of the board of directors of SciGen Ltd. Since 29 June 2009 she has been holding the position of a Member of the Supervisory Board of the Company.
Wiesław Walendziak – Member of the Board
Higher education. He graduated in 1987 from the University of Gdańsk. He started professional work in a Gdańsk located cooperative "Świetlik", where he performed work at heights (1987-1989). In 1989-1991 he was the publisher and chief editor of "Młoda Polska" weekly. In 1990 he was a holder of the scholarship of German Marshall Foundation in USA. In 1991-1993 he worked as a producer and author of TV programs “Bez znieczulenia” and “Lewiatan". In 1993 he was CEO of Telewizja Polsat S.A. and in 1994-1996 the president of the managing board of Telewizja Polska S.A. and a member of the Administrative Board of the European Broadcasting Union in Geneva. He was a Member of the Parliament in the 3rd term of the Sejm and the head of the Chancellery of the Prime Minister in 1997-2001. In 1998-1999 he was the initiator of talks and the first negotiator on behalf of the Polish government on granting compensations to forced workers of the Third Reich. In 1999-2002 he was a member of the Civil Service Board and in 2000-2001 he was a member of the Council of Europe Parliamentary Assembly in Strasbourg. In 2001-2004 he was a Member of the Parliament (4th term of the Sejm) and the chairman of the Sejm state treasury committee. In 2005 he became the vice-president of the managing board of Prokom Investments SA. He runs business activity as a natural person under the name “Walendziak Doradztwo”. He is also the president of the managing board of Polski Operator Telewizyjny S.A. dealing with implementation of ground digital television. Moreover, he is a member of the supervisory boards of Bioton S.A., Polnord S.A. Radio Pin S.A.
drukujBioton WorldWide
Requires the Flash plugin. If the plugin is already installed, click here.
GPW
Press Contact
Contact for media:
Kinga Fromlewicz
Mobile: +48 506 025 066
Contact for investors:
Grzegorz Kubica